Skip to main content
. Author manuscript; available in PMC: 2013 Jun 25.
Published in final edited form as: Epilepsy Behav. 2009 Nov 4;16(4):609–616. doi: 10.1016/j.yebeh.2009.09.024

Table 1. Cognitive Outcomes for Valproate Subjects Across Human Studies.

Study Enrollment
Design
Blinded to
AED
Valproate
MonoTx
Other AED
MonoTx
Significant
Outcome
Adab
2004[10]
Retrospective No N=41 Carbamazepine Phenytion WISC-III[17]
Verbal IQ
Gaily
2004[8]
Prospective Yes N=13 Carbamazepine WPPSI-R[18]
or WISC-
R[19] Verbal
IQ
Eriksson
2005[6]
Prospective Yes N=21 Carbamazepine WISC-III IQ
[17]
Meador
2009[7]
Prospective Yes N=53 Carbamazepine
Lamotrigine
Phenytoin
DAS IQ [20]
and BMDI
[21]

AED = Antiepileptic drug; MonoTx = Prenatal exposure to AED monotherapy; DAS = Differential Abilities Scales [20], a standardized intelligence quotient that measures generalized cognitive ability (GCA), administered to this cohort at 36–45 months; BMDI = Bayley Mental Development Index[21], a standardized behavioral measure of cognitive development, administered to this cohort at 21–34 months; WISC = Wechsler Intelligence Scale for Childen [17, 19]; WPPSI = Wechsler Preschool and Primary Scale of Intelligence [18].